AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026Net selling: insiders sold $738K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$738K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 7 added, 3 cutMore adding
Market overview
Fundamentals Sep 12- Open
- $135.07
- 52-wk high
- $135.09
- High
- $135.07
- 52-wk low
- $35.39
- Low
- $135.07
- Prev close
- $135.07
- Mkt cap
- $10.22B
- Volume
- 0
- Beta
- 0.33
- P/B
- 8.6x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -32.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about APGE filings
Are insiders buying or selling Apogee Therapeutics, Inc. Common Stock (APGE) stock?
Net selling: insiders sold $738K and bought $0 of APGE stock on the open market in the 90 days to Oct 11, 2026, according to SEC Form 4 filings. $738K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Dambkowski, Carl (Chief Medical Officer), who sold $738K. The latest filing was on Aug 8, 2026.
Which members of Congress have traded APGE recently?
None. No member of Congress disclosed a APGE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this APGE smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- MI
Millennium
$190.2M
added
- BA
Balyasny
$184.1M
added
- QR
Qube Research
$87.6M
bought
What insiders are doing
How top traders are positioned
No tracked top-trader positions in APGE right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 3.6% below what analysts expected.
Last report
Aug 10, 2026
Period ending
Jun 30, 2026
Earnings per share
-$1.10 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 10, 2026 | -$1.14 / -$1.10Alpha Vantage | -3.64% miss | Unavailable | Unavailable |
| Mar 31, 2026 | May 11, 2026 | -$1.06 / -$1.13Alpha Vantage | +6.19% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 2, 2026 | -$1.03 / -$0.62Alpha Vantage | -66.13% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 10, 2025 | -$1.11 / -$1.15Alpha Vantage | +3.48% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 11, 2025 | -$1.13 / -$1.05Alpha Vantage | -7.62% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 12, 2025 | -$0.95 / -$1.19Alpha Vantage | +20.17% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 3, 2025 | -$1.18 / -$0.62Alpha Vantage | -90.32% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.86 / -$0.74Alpha Vantage | -16.22% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | $400.0K | -$400.0K | $408.0K | — |
| Gross profit | -$400.0K | $400.0K | -$408.0K | — |
| What it spent | ||||
| Research and development | $54.2M | $58.4M | $60.8M | $67.3M |
| Sales and admin | $17.1M | $20.1M | $22.0M | $24.3M |
| Other operating costs | — | — | — | $4.4M |
| Total operating expenses | $70.9M | $78.5M | $82.4M | $96.0M |
| What was left | ||||
| Operating profit | -$71.3M | -$78.1M | -$82.8M | -$96.0M |
| Interest on debt | — | — | — | $1.6M |
| Profit before tax | -$65.0M | -$69.3M | -$74.0M | -$85.8M |
| Tax | $61.0K | $62.0K | $79.0K | $78.0K |
| Net profit | -$65.0M | -$69.4M | -$74.1M | -$85.9M |
| EBITDA | -$64.6M | -$68.9M | -$73.6M | -$84.2M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace